To evaluate the hypothesis that infectious adverse events following prostatic artery embolization (PAE) are comparable to those following other treatment options for benign prostatic hyperplasia (BPH) ...
UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
PAM50 Molecular Subtypes in Prostate Cancer Trials - Krishnan Patel & George Zhao ...
Current clinical risk stratification for determining neoadjuvant chemotherapy (NAC) usage in nonmetastatic upper tract urothelial carcinoma (UTUC) is frequently inaccurate. This uncertainty leads to ...
ASTRO 2026: Circulating Tumor DNA Dynamics in Oligometastatic Urothelial Carcinoma Treated with Stereotactic Body Radiation Therapy ASTRO 2026: Trimodality Bladder Preservation Therapy Outcomes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results